Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company with over 20 years of experience in developing and commercializing polymerase chain reaction (PCR)-based applications for DNA production. Through its majority-owned subsidiary, LineaRx Inc., the Company is commercializing its LineaDNA and LineaIVT platforms to enable the manufacture of next-generation nucleic acid-based therapies.
Visit adnas.com for more information. Follow us on X and LinkedIn.
Forward-Looking Statements
The statements made by Applied DNA Sciences in this press release may be "forward-looking" in nature within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNA's future plans, projections, strategies, and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. These forward-looking statements are based largely on the Company's expectations and projections about future events and future trends affecting our business and are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. Actual results could differ materially from those projected due to the Company's history of net losses, limited financial resources, substantial doubt regarding its ability to continue as a going concern, unknown future ability to continue its listing on the Nasdaq Capital Market, unknown future demand for its biotherapeutics products and services, the unknown amount of revenues and profits that will result from our LineaDNA and/or LineaIVT platforms, the fact that there has never been clinical trial material and/or a commercial drug product produced utilizing the LineaDNA and/or LineaIVT platforms, as well as various other factors detailed from time to time in Applied DNA's SEC reports and filings, including its Annual Report on Form 10-K filed on December 17, 2024, its Quarterly Reports on Form 10-Q filed on February 13, 2025, and May 15, 2025, and other reports it files with the SEC, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law.
Applied DNA Sciences Contact:
Investor Relations contact: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: https://investors.adnas.com
SOURCE: Applied DNA Sciences, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Nvidia Stock Falls Despite Bullish Calls From KeyBanc and Susquehanna
This article first appeared on GuruFocus. Aug 20 Nvidia Corporation (NASDAQ:NVDA) shares fell about 2.5% on Wednesday morning even as two Wall Street firms raised their price targets ahead of the company's quarterly earnings report next week. Warning! GuruFocus has detected 5 Warning Signs with NVDA. KeyBanc Capital Markets lifted its target on the chipmaker to $215 from $190, while keeping an Overweight rating. Analyst John Vinh said he expects Nvidia to post strong fiscal second-quarter results for July but guide slightly below consensus for the October quarter. He noted that the company's outlook likely excludes revenue from China due to pending license approvals and uncertain timing. According to Vinh, including China could add an incremental $2 billion to $3 billion in sales, driven by the H20 and RTX6000D processors. Susquehanna also raised its price target, moving to $210 from $180, and kept a Positive rating. Analyst Christopher Rolland sees continued momentum across Nvidia's data center business. Consensus estimates call for Nvidia to earn $1.01 per share on revenue of $45.92 billion in the coming quarter. The company is scheduled to release results on Aug. 27. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
NBC News
20 minutes ago
- NBC News
Nasdaq, S&P 500 end lower as investors sell tech, buy less pricey sectors
The Nasdaq and S&P 500 fell on Wednesday as investors sold tech stocks and moved into less highly valued sectors, as they also awaited remarks from Federal Reserve officials at their Jackson Hole symposium this week. Tech stocks, which drove much of the recovery from Wall Street's April selloff, have been pulling back. The S&P 500 technology index .SPLRCTwas down on the day, while sectors such as energy, healthcare and consumer staples rose. 'A broader lens tells you it's more of a rotation than a true sell off,' said Allspring's senior portfolio manager, Bryant van Cronkhite. 'Tech valuations look extended in the context of inflated spending today. Number two, I would say that there are a lot of pockets of the market that look very attractive from a valuation standpoint and they've been broadly ignored.' According to preliminary data, the S&P 500 lost 16.40 points, or 0.26%, to end at 6,394.97 points, while the Nasdaq Composite lost 144.76 points, or 0.68%, to 21,170.19. The Dow Jones Industrial Average rose 1.48 points, or 0.00%, to 44,923.75. Analysts listing other factors behind the tech sell-off mentioned OpenAI CEO Sam Altman's comments last week about artificial intelligence stocks being 'in a bubble,' and a Massachusetts Institute of Technology study that showed many tech companies were struggling to translate AI into actual profits. Some investors also worried about government interference in the private sector. President Donald Trump's administration is looking into taking equity stakes in chip firms such as IntelINTC.O, weeks after unprecedented revenue-sharing deals with Nvidia and AMD. Nvidia, Advanced Micro Devices, Intel and Micron fell. Nvidia's quarterly results on August 27 are keenly awaited for clues on demand for artificial intelligence. Other megacap growth names such as Apple and Meta also came under pressure. Minutes from the Fed's July meeting, where interest rates were left unchanged, showed almost all policymakers viewed it as appropriate to maintain the target range for the federal funds rate at 4.25% to 4.50%, despite two dissenters. Fed Chair Jerome Powell is expected to speak on Friday at the central bank's annual conference in Jackson Hole, Wyoming. His remarks will be closely watched for policy signals. Investors have been pricing in a 25-basis-point rate cut in September, according to data compiled by LSEG. Meanwhile, investors also monitored Trump's call for the resignation of Fed Governor Lisa Cook, with the president citing allegations that she was involved in mortgage fraud. Earnings from big retailers, seen as a barometer for the health of the American consumer, are also due this week as sentiment has taken a hit from concerns that tariffs could drive prices higher. Target after the company named a new CEO and retained its annual forecasts that were lowered in May.
Yahoo
28 minutes ago
- Yahoo
S&P 500 Gains and Losses Today: Intel Stock Retreats; Analog Devices Jumps After Strong Earnings
Key Takeaways The S&P 500 declined 0.2% on Wednesday, Aug. 20, 2025, as tech stocks slid and minutes from the latest Federal Reserve meeting highlighted policymakers' concerns about tariffs and inflation. Intel stock gave back some of its recent gains as discussions about the U.S. government possibly acquiring an equity stake remained in focus. Analog Devices posted better-than-expected quarterly results, and shares of the chipmaker pushed higher. Major U.S. equities indexes were mixed on Wednesday as tech stocks slid and minutes from the latest Federal Reserve meeting highlighted policymakers' concerns about tariffs and inflation. The S&P 500 lost 0.2% Wednesday, marking the fourth straight losing session for the benchmark index. The tech-heavy Nasdaq fell 0.7%, while the Dow ended with a gain of less than 0.1%. Intel (INTC) stock gave back some of its recent gains, dropping 7% to log the S&P 500's weakest performance on Wednesday as discussions about the U.S. government possibly acquiring an equity stake remained in focus. The drop reversed the stock's jump yesterday after the announcement of a major investment by Japanese investment firm SoftBank (SFTBY). Shares of Micron Technology (MU) and other chipmakers with CHIPS Act grants also fell, following reports the Trump administration could look to strike similar deals with them as the one it's weighing with Intel. Micron shares lost 4%. Shares of Target (TGT) slipped 6.3% after the retailer said that CEO Brian Cornell would step down. Target tapped Michael Fiddelke—its current chief operating officer and a company veteran who has played a key role in plans to reshape operations—to take over the CEO role effective early next year. The announcement of the leadership change came as Target reported a decline in sales, though they topped analysts' expectations, and profits that matched estimates. Analog Devices (ADI) shares avoided the downward pressure on the broader semiconductor industry, surging 6.3% to notch the S&P 500's strongest daily gain. The manufacturer of sensor and power management chips topped quarterly earnings estimates, and provided a better-than-expected outlook. The company highlighted resilient demand trends despite trade-related uncertainty. Medtronic (MDT) shares added 3.7% after the medical device maker announced that it would add two new members to its board of directors following the accumulation of a significant position by activist investor Elliott Management. UBS and Wells Fargo lifted their price targets on Medtronic stock following the news. Shares of agribusiness and food products giant Bunge (BG) gained 3.1% as JPMorgan kicked off coverage of the stock with an "overweight" rating. Analysts indicated that the company could be set to benefit from policies related to biofuels in the U.S. potentially boosting demand for soybean oil. The firm also suggested efficiencies stemming from the acquisition of Netherlands-based Viterra could help drive Bunge's earnings growth. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
